Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Clinical trial NCT01316250 · COMPLETED
Trial details
- NCT number
- NCT01316250
- Sponsor
- American University of Beirut Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2025-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.